eRapid Technology for the multiplexed detection of sepsis biomarker (IMAGE)

Wyss Institute for Biologically Inspired Engineering at Harvard

eRapid Technology for the multiplexed detection of sepsis biomarker

Caption

Wyss Institute researchers have developed eRapid technology as an affinity-based, low-cost electrochemical diagnostic sensor platform for the multiplexed detection of clinically relevant sepsis biomarkers in whole blood.

Credit

Wyss Institute at Harvard University

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.